Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00036309
|United States, North Carolina|
|For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)|
|Durham, North Carolina, United States|